Generic Name and Formulations:
Ciprofloxacin 0.3%, fluocinolone acetonide 0.025%; otic soln; preservative-free.
Arbor Pharmaceuticals, LLC
Indications for OTOVEL:
Acute otitis media in pediatric patients with tympanostomy tubes due to S. aureus, S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa.
Adults and Children:
<6 months: not studied. ≥6 months: 1 vial (0.25mL) into affected ear(s) twice daily for 7 days.
Viral otic infections (eg, varicella, herpes simplex, fungal).
Discontinue if superinfection or hypersensitivity occurs. Reevaluate if no improvement after 1 week or if ≥2 episodes occur within 6 months. Pregnancy. Nursing mothers.
Antibiotic (quinolone) + steroid.
Otorrhea, excessive granulation tissue, ear infection, ear pruritus, tympanic membrane disorder, auricular swelling, balance disorder.
Single-dose vials (0.25mL)—14
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics